Parathyroid hormone suppresses insulin signaling in adipocytes

被引：63

作者：

Chang, Eugene ^{[1
]}

Donkin, Shawn S. ^{[1
]}

Teegarden, Dorothy ^{[1
]}

机构：

[1] Purdue Univ, Interdept Nutr Program, W Lafayette, IN 47907 USA

来源：

MOLECULAR AND CELLULAR ENDOCRINOLOGY | 2009年 / 307卷 / 1-2期

关键词：

Insulin receptor; Insulin receptor substrate-1; Glucose; Parathyroid hormone; NECROSIS-FACTOR-ALPHA; KAPPA-B ACTIVATION; 3T3-L1; ADIPOCYTES; PRIMARY HYPERPARATHYROIDISM; RECEPTOR SUBSTRATE-1; GLUCOSE-INTOLERANCE; TNF-ALPHA; EXPRESSION; RESISTANCE; PHOSPHORYLATION;

D O I：

10.1016/j.mce.2009.03.024

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Previous reports suggest that parathyroid hormone (PTH) is associated with insulin resistance. This research investigated the effects of PTH on insulin signaling in differentiated 3T3-L1 adipocytes. PTH (10 nM, 24 h) treatment induced a reduction in insulin-stimulated glucose uptake, AKT activity (phosphorylated AKT/total AKT protein expression) and a decrease in GLUT4 and IRS-1 protein expression compared to vehicle treated controls in differentiated adipocytes. PTH treatment also induced increased phosphorylation of IRS-1 on serine 307, which suppresses insulin signaling. In addition, treatment of cells with adenyl cyclase inhibitor SQ52236 ameliorated the effects of PTH on insulin-stimulated glucose uptake, whereas inhibition of phospholipase C alpha (U73122) did not significantly alter the effects of PTH. Thus, PTH treatment of differentiated 3T3-L1 adipocytes suppresses insulin-stimulated glucose uptake and insulin signaling via cAMP pathway, potentially through the phosphorylation of IRS-1 at serine 307. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：77 / 82

页数：6

共 38 条

[1] Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver [J].

Abel, ED ;

Peroni, O ;

Kim, JK ;

Kim, YB ;

Boss, O ;

Hadro, E ;

Minnemann, T ;

Shulman, GI ;

Kahn, BB .

NATURE, 2001, 409 (6821) :729-733

[2] Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action [J].

Aguirre, V ;

Werner, ED ;

Giraud, J ;

Lee, YH ;

Shoelson, SE ;

White, MF .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1531-1537

[3] The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].

Aguirre, V ;

Uchida, T ;

Yenush, L ;

Davis, R ;

White, MF .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054

[4] ROLE OF PARATHYROID-HORMONE IN THE GLUCOSE-INTOLERANCE OF CHRONIC RENAL-FAILURE [J].

AKMAL, M ;

MASSRY, SG ;

GOLDSTEIN, DA ;

FANTI, P ;

WEISZ, A ;

DEFRONZO, RA .

JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (03) :1037-1044

[5] Activation of NF-κB in human osteoblasts by stimulators of bone resorption [J].

Ali, NN ;

Gilston, V ;

Winyard, PG .

FEBS LETTERS, 1999, 460 (02) :315-320

[6] EXTRACELLULAR CA2+ SENSING, REGULATION OF PARATHYROID CELL-FUNCTION, AND ROLE OF CA2+ AND OTHER IONS AS EXTRACELLULAR (1ST) MESSENGERS [J].

BROWN, EM .

PHYSIOLOGICAL REVIEWS, 1991, 71 (02) :371-411

[7] Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level [J].

Chiu, KC ;

Chuang, LM ;

Lee, NP ;

Ryu, JM ;

McGullam, JL ;

Tsai, GP ;

Saad, MF .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (11) :1501-1505

[8] TNFα and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics [J].

Dai, JC ;

He, P ;

Chen, X ;

Greenfield, EM .

BONE, 2006, 38 (04) :509-520

[9]

DeFronzo R A, 1983, Kidney Int Suppl, V16, pS102

[10]

FARESE RV, 2005, INSULIN SENSITIVE PR, P593

← 1 2 3 4 →